Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New cytokine production inhibitors revealed by SS Pharm.

Nov. 21, 1997

FDA advisory committee to review rotavirus vaccine

Nov. 20, 1997

BCH-1393 stimulates CTL response in vitro and in vivo

Nov. 19, 1997

Basiliximab reduces renal allograft rejection in phase III trial

Nov. 19, 1997

Second report of clinical efficacy for rotavirus vaccine

Nov. 18, 1997

Novartis submits BLA for Simulect in U.S.

Nov. 17, 1997

Immunological method for preventing ALL in children available for licensing

Nov. 17, 1997

Peptide + ciclosporin combination improves renal allograft survival and function

Nov. 14, 1997

Anti-CD45 MAb prolongs islet xenograft survival in diabetic mice

Nov. 14, 1997

BioChem Pharma moves cell culture-based influenza vaccine to phase II/III

Nov. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...